Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review

High incidence of neutropenia in patients with prolonged ceftaroline exposure

(2016) Kari J. Furtek et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Adverse Drug Reactions Associated with Ceftaroline Use: A 2-Center Retrospective Cohort

(2016) Kimberly G. Blumenthal et al.   Journal of Allergy and Clinical Immunology-In Practice

Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA

(2015) Martin E. Stryjewski et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature

(2015) Sanjiv M. Baxi et al.   INFECTION

Successful treatment of meticillin-resistant Staphylococcus aureus (MRSA) aortic prosthetic valve endocarditis with prolonged high-dose daptomycin plus ceftaroline therapy

(2015) Burke A. Cunha et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Agranulocytosis with Ceftaroline High-Dose Monotherapy or Combination Therapy with Clindamycin

(2015) Neilmegh L. Varada et al.   PHARMACOTHERAPY

PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

(2014) S. Wesley Long et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy

(2014) A. M. Casapao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

(2014) Dennis L. Stevens et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline

(2014) George Sakoulas et al.   CLINICAL THERAPEUTICS

Ceftaroline CSF concentrations in a patient with ventriculoperitoneal shunt-related meningitis

(2014) S. S. Kuriakose et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Successful use of ceftaroline for the treatment of MRSA meningitis secondary to an infectious complication of lumbar spine surgery

(2014) M. A. Balouch et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective

(2014) R. A. Alm et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Methicillin-resistantStaphylococcus aureusnosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients

(2014) Timothy R. Pasquale et al.   JOURNAL OF CHEMOTHERAPY

Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience

(2014) Ananthakrishnan Ramani et al.   JOURNAL OF CHEMOTHERAPY

High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline

(2014) Rupali Jain et al.   PHARMACOTHERAPY

Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy

(2013) John Bucheit et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature

(2013) Hari M. Polenakovik et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

(2012) S. J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity

(2012) Warren E. Rose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy

(2012) T. T. Ho et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients

(2012) Jennifer C. Lin et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Ceftaroline Fosamil: A Novel Broad-Spectrum Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus

(2011) Margaret R Jorgenson et al.   ANNALS OF PHARMACOTHERAPY

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

(2011) A. Dhand et al.   CLINICAL INFECTIOUS DISEASES

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates

(2010) Céline Vidaillac et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Staphylococcus aureusBacteremia: Epidemiology, Pathophysiology, and Management Strategies

(2009) Christoph K. Naber   CLINICAL INFECTIOUS DISEASES